Back to dashboard
All PlansCoverageMedium impact

Genetic Testing for Cardiac Ion Channelopathies

Blue Cross & Blue Shield of Mississippi·MS · Cardiology, Family Medicine, Internal Medicine +1 more·Medical Policy
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply
—

Summary

New medical policy A.2.04.43 establishes coverage criteria for genetic testing for cardiac ion channelopathies including long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome. The policy provides detailed clinical background and genetic information but does not specify billing codes or coverage determination criteria in the provided excerpt.

Action Required

Action needed
Immediately: Billing team should review complete policy A.2.04.43 to identify specific coverage criteria, prior authorization requirements, and applicable CPT codes for genetic testing related to cardiac ion channelopathies. Update billing guidelines for cardiology and genetics services accordingly. Contact insurance to clarify any coverage determination requirements not specified in this policy excerpt.

Related policy hubs